Helping Regulators and Drug Developers Understand the Challenges of Living with Fabry Disease
Jack Johnson, co-founder of the Fabry Support and Information Group, discusses his experience with the condition, his journey into advocacy, and a recent externally-led Patient-Focused Drug Development meeting to help regulators and drug developers understand the need for new therapies to address the challenges of living with the disease.